# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-23-000050
Filing Date
2023-08-09
Accepted
2023-08-09 16:03:44
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20230630.htm iXBRL | 10-Q | 1144287
2 | EX-10.1 | a101_ligand-directorcompen.htm | EX-10.1 | 29569
3 | EX-31.1 | lgnd_63023exhibit311.htm | EX-31.1 | 15159
4 | EX-31.2 | lgnd_63023exhibit312.htm | EX-31.2 | 15429
5 | EX-32.1 | lgnd_63023exhibit321.htm | EX-32.1 | 11158
11 |  | lgnd-20230630_g1.jpg | GRAPHIC | 51754
| Complete submission text file | 0000886163-23-000050.txt |  | 7089631

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20230630.xsd | EX-101.SCH | 44160
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20230630_cal.xml | EX-101.CAL | 87777
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20230630_def.xml | EX-101.DEF | 240254
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20230630_lab.xml | EX-101.LAB | 710907
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20230630_pre.xml | EX-101.PRE | 425201
57 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20230630_htm.xml | XML | 1019102

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 231155026
SIC: 2834 Pharmaceutical Preparations